Cargando…
Improved Glycemic Control With the Multi-Receptor Tyrosine Kinase Inhibitor Pazopanib
Autores principales: | Böhm, Steffen, Hess, Dagmar, Gillessen, Silke, Brändle, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898909/ https://www.ncbi.nlm.nih.gov/pubmed/20508227 http://dx.doi.org/10.2337/dc10-0436 |
Ejemplares similares
-
Gray Hair Associated with the Multitargeted Receptor Tyrosine Kinase Inhibitor Pazopanib
por: Yun, Hwan-Jung, et al.
Publicado: (2015) -
Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2012) -
Glycemic Control and Hypoglycemia: Is the Loser the Winner?: Response to Musen et al.
por: Perlmuter, Lawrence C., et al.
Publicado: (2009) -
Glycemic Control and Hypoglycemia: Is the Loser the Winner?: Response to Perlmuter et al.
por: Musen, Gail, et al.
Publicado: (2009) -
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib
por: Wilding, Christopher P, et al.
Publicado: (2019)